Did you know that there are microbes living in our airways, like in the gut and on the skin? The human respiratory tract (RT) is a complex and dynamic environment, harbouring a diverse community of microorganisms collectively known as the respiratory tract microbiota. Far from being sterile, this microbial ecosystem plays a crucial role in maintaining respiratory health.
Among its many inhabitants, Streptococcus pneumoniae, commonly referred to as pneumococcus, stands out as a frequent coloniser of the upper respiratory tract, particularly the nasopharynx. In fact, it is estimated that up to 40-50% of healthy children and 20-30% of healthy adults are asymptomatic carriers of pneumococcus. While often living harmlessly as part of the RT microbiota, pneumococcus is also a notorious opportunistic pathogen capable of causing a range of severe diseases.

Factors influencing the RT microbiota
The composition and stability of the RT microbiota are influenced by a myriad of factors, both intrinsic and environmental:
- Age and genetics: These inherent factors play a role in shaping an individual’s unique microbial profile.
- Environmental exposures: Air pollution and, most notably, exposure to smoke (both active and passive), significantly alter the balance of the RT microbiota. Smoking, for instance, has been shown to reduce the diversity of microbial species and promote the colonisation of potential pathogens like Haemophilus influenzae and Moraxella catarrhalis, alongside pneumococcus, thereby increasing susceptibility to respiratory infections.
- Lifestyle factors: Diet and antibiotic use can also impact the microbial community.
- Viral infections: Infections such as influenza can temporarily disrupt the microbiota, creating a window of opportunity for bacterial superinfections.
The effects of dysbiosis
Dysbiosis, an imbalance in the composition or function of the RT microbiota, is increasingly recognised as a contributing factor to various respiratory diseases. While a healthy microbiota can protect against pathogen invasion, dysbiosis can compromise these defences. This disruption has been linked to some common respiratory illnesses including:
- Pneumonia: An altered microbiota can facilitate the overgrowth of pathogenic bacteria, leading to inflammation and impaired lung function.
- Bronchitis: Dysbiosis can contribute to inflammation of the bronchial tubes.
- Chronic obstructive pulmonary disease (COPD): Persistent dysbiosis may exacerbate symptoms and contribute to disease progression.
- Asthma and cystic fibrosis: Emerging research also suggests a connection between RT microbiota dysbiosis and these conditions.
Sustaining the balance
Maintaining the delicate balance of the RT microbiota is paramount for preventing respiratory infections and promoting overall respiratory health.
- Lifestyle interventions: Avoiding exposure to smoke and air pollutants can significantly contribute to a healthier microbial environment.
- Dietary approaches: A balanced diet rich in prebiotics and probiotics may also play a role in supporting a diverse and robust microbiota, although more research is needed in this specific area for respiratory health.
The role of vaccination
Crucially, vaccination stands as one of the most effective strategies for preventing infections caused by specific respiratory pathogens. In the context of pneumococcus, pneumococcal vaccine significantly reduces the incidence of pneumococcal diseases such as pneumonia, meningitis, and otitis media. While vaccination primarily targets the pathogen, it indirectly contributes to maintaining the balance of the RT microbiota by preventing the overgrowth and pathogenic activity of a common coloniser that can severely disrupt the delicate ecosystem. By reducing the burden of pneumococcal disease, vaccination helps preserve the overall health and resilience of the respiratory tract microbial community.
The respiratory tract microbiota is a vital component of our health, acting as a frontline defence against pathogens. Understanding the factors that influence its balance and recognising the role of dysbiosis in disease are crucial for developing effective preventive strategies. Through healthy lifestyle choices and the continued success of vaccination programs, particularly against common colonisers like pneumococcus, we can better protect the delicate microbial ecosystem of our respiratory tract and safeguard ourselves against serious infections.
References:

